Treatment of osteoid osteoma by means of CT-guided radiofrequency

Condés, J.M. Sarabia; Martínez, J. M.; Redondo, P. Villamor; Fernández, Marcos; Barrio, Ana Blanco

doi:10.1016/s1988-8856(10)70206-6

Cited by 2 publications

(2 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…6,10,24 Its cost is significantly lower than that of traditional open surgery due to reduced hospital costs. 25 The potential complications of percutaneous radiofrequency thermoablation are cellulitis, 13 bleeding and infection at the skin entry site, intraoperative vasomotor instability, 20 and clubfoot due to temporary muscle contraction. 11 Extreme caution must be exercised when operating on lesions less than 1 cm from structures such as nerves and vessels 11,15 or on superficial lesions that are at risk for soft tissue damage and burns from thermal necrosis.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Treatment of Osteoid Osteoma With CT-guided Percutaneous Radiofrequency Thermoablation

Palma¹,

Candelari²,

Antico³

et al. 2013

Orthopedics

View full text Add to dashboard Cite

Osteoid osteoma is a benign bone tumor with a male predominance occurring mainly in children and young adults. The most common symptom is intermittent pain that worsens at night and is at least partially relieved by nonsteroidal anti-inflammatory drugs. The purpose of this study was to assess the long-term effectiveness of computed tomography-guided percutaneous radiofrequency thermoablation in patients with a minimum follow-up of 2 years. Twenty patients with osteoid osteoma (15 men and 5 women) with a mean age of 20.7 years (range, 4-61 years; 12 patients aged 20 years or younger) underwent computed tomography-guided percutaneous radiofrequency thermoablation. Lesion sites were the femur (n=9), tibia (n=7), pelvis (n=1), talus (n=1), cuneiform bone (n=1), and humerus (n=1). Mean follow-up was 44 months (range, 3-106 months). Pain relief was significant in 95% of patients; it disappeared within 24 hours in 14 patients, within 3 days in 4, and within 7 days in 1. The patient with persistent symptoms underwent another percutaneous radiofrequency thermoablation procedure that was successful. The difference between pre- and postoperative pain was significant (P ≤ .01). No recurrences occurred. Computed tomography-guided percutaneous radiofrequency thermoablation is a safe, minimally invasive, and economical procedure with high technical and clinical success rates, and it effectively and durably enhances quality of life.

show abstract

Section: Discussionmentioning

confidence: 99%

“…7,13,21,22,26 The percutaneous ra-diofrequency thermoablation settings reported in previous reports are 4 minutes at 90°C 10,13,20,24 or 6 minutes at 80°C. 25 The current authors applied a prolonged ablation time of 6 minutes at 90°C.…”

Section: Discussionmentioning

confidence: 99%